Public list: Smart Money VCs (6328) Pharma Startups (4734) Rare Diseases (230)

Vtesse is a rare disease company dedicated to developing drugs for patients suffering from underserved diseases. Vtesse closely collaborates with National Institutes of Health (NIH), parents, patient support groups and other academic institutions to advance VTS-270 towards regulatory approval. Vtesse is also progressing earlier stage programs for lysosomal storage diseases, including next-generation therapeutics for NPC.

Vtesse is a rare disease company dedicated to developing drugs for patients suffering from underserved diseases. Vtesse closely collaborates with National Institutes of Health (NIH), parents, patient support groups and other academic institutions to ...Show all

Company (Acquired)

Phone: 240-801-9261

Fax:

910 Clopper Road
Suite 220 S
Gaithersburg, 20878
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Vtesse $42M Apr 3, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Vtesse Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
New Enterprise AssociatesVenture CapitalMenlo Park, California, United StatesSeries A - II, Series A, Seed VC
Bay City CapitalVenture CapitalSan Francisco, California, United StatesSeries A - II, Series A
Lundbeckfond VenturesVenture CapitalCopenhagen East, DenmarkSeries A - II, Series A
Alexandria Venture InvestmentsCorporate VenturePasadena, California, United StatesSeries A - II, Series A
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hydroxypropyl beta-cyclodextrin compositions and methods Oct 07, 2016 Jun 13, 2017 Patent
Hydroxypropyl beta-cyclodextrin compositions and methods Apr 27, 2017 Application
Hydroxypropyl beta-cyclodextrin compositions and methods Jun 09, 2016 Application